EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 370 filers reported holding EXELIXIS INC in Q3 2020. The put-call ratio across all filers is 2.74 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $1,176,000 | -56.7% | 64,581 | -43.5% | 0.02% | -55.3% |
| Q2 2020 | $2,713,000 | +513.8% | 114,251 | +356.6% | 0.05% | +422.2% |
| Q3 2019 | $442,000 | -64.7% | 25,024 | -57.3% | 0.01% | -57.1% |
| Q2 2019 | $1,251,000 | -59.9% | 58,544 | -55.3% | 0.02% | -72.4% |
| Q1 2019 | $3,116,000 | +217.3% | 130,916 | +162.1% | 0.08% | +153.3% |
| Q4 2018 | $982,000 | +167.6% | 49,944 | +141.3% | 0.03% | +328.6% |
| Q3 2018 | $367,000 | -32.8% | 20,700 | -16.1% | 0.01% | -22.2% |
| Q1 2018 | $546,000 | +65.5% | 24,667 | +126.6% | 0.01% | +125.0% |
| Q4 2017 | $330,000 | -95.5% | 10,887 | -96.3% | 0.00% | -95.3% |
| Q2 2017 | $7,299,000 | +761.7% | 296,330 | +658.8% | 0.09% | +760.0% |
| Q1 2017 | $847,000 | +124.1% | 39,051 | -41.8% | 0.01% | 0.0% |
| Q4 2015 | $378,000 | +587.3% | 67,052 | +453.9% | 0.01% | +233.3% |
| Q2 2013 | $55,000 | – | 12,106 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 15,001,073 | $199,507,000 | 56.91% |
| Sargent Investment Group, LLC | 1,032,560 | $18,193,000 | 3.40% |
| Bellevue Group AG | 3,930,700 | $69,259,000 | 1.10% |
| CAPITAL MANAGEMENT CORP /VA | 231,880 | $4,086,000 | 1.04% |
| Orbimed Advisors | 3,753,700 | $66,140,000 | 0.94% |
| TEALWOOD ASSET MANAGEMENT INC | 121,848 | $2,147,000 | 0.90% |
| FARALLON CAPITAL MANAGEMENT LLC | 7,500,000 | $132,150,000 | 0.89% |
| Chicago Capital, LLC | 806,113 | $14,204,000 | 0.87% |
| Penn Capital Management Company, LLC | 456,587 | $8,045,000 | 0.84% |
| AJO, LP | 7,636,882 | $134,561,000 | 0.80% |